TengjieCPU (Talk | contribs) |
|||
Line 196: | Line 196: | ||
<div class="media-body"> | <div class="media-body"> | ||
<h3 class="">Professor Yong Yang</h3> | <h3 class="">Professor Yong Yang</h3> | ||
− | <h4> | + | <h4><br>Vice president of Dug Science Research Institute, |
<br> director of New Drug Safety Assessment Center | <br> director of New Drug Safety Assessment Center | ||
<br> Pf. Yang mainly engaged in molecular medicine based on transformation of molecular targeted anti-tumor | <br> Pf. Yang mainly engaged in molecular medicine based on transformation of molecular targeted anti-tumor | ||
Line 216: | Line 216: | ||
<div class="media-body"> | <div class="media-body"> | ||
<h3 class="">Professor Hanmei Xu</h3> | <h3 class="">Professor Hanmei Xu</h3> | ||
− | <h4> | + | <h4><br>Professor of Life Science and Technology |
+ | <br>China Pharmaceutical University, doctoral tutor, director of marine | ||
pharmacy. Since 2002 in Nanjing University National Key Laboratory of Pharmaceutical Biotechnology for | pharmacy. Since 2002 in Nanjing University National Key Laboratory of Pharmaceutical Biotechnology for | ||
postdoctoral research period, began anti-tumor protein and peptide research. At the end of 2004 to the | postdoctoral research period, began anti-tumor protein and peptide research. At the end of 2004 to the | ||
Line 236: | Line 237: | ||
<div class="media-body"> | <div class="media-body"> | ||
<h3 class="">Professor Bin Li</h3> | <h3 class="">Professor Bin Li</h3> | ||
− | <h4>Shanghai Institute of Immunology, | + | <h4><br>Shanghai Institute of Immunology, |
<br> Shanghai Jiaotong University. | <br> Shanghai Jiaotong University. | ||
<br> Professor Bin Li is now the vice director of Shanghai Institute of Immunology, Distinguished Professor | <br> Professor Bin Li is now the vice director of Shanghai Institute of Immunology, Distinguished Professor | ||
Line 259: | Line 260: | ||
<div class="media-body"> | <div class="media-body"> | ||
<h3 class="">Weiwei Hu Ph.D.</h3> | <h3 class="">Weiwei Hu Ph.D.</h3> | ||
− | <h4>Center for New Drug Safety Evaluation and Research, | + | <h4><br>Center for New Drug Safety Evaluation and Research, |
<br> China Pharmaceutical University. | <br> China Pharmaceutical University. | ||
<br> Dr. Weiwei Hu graduated from Animal Medical College of Nanjing Agricultural University in June 2016. | <br> Dr. Weiwei Hu graduated from Animal Medical College of Nanjing Agricultural University in June 2016. | ||
Line 279: | Line 280: | ||
<div class="media-body"> | <div class="media-body"> | ||
<h3 class="">Hui Huang.</h3> | <h3 class="">Hui Huang.</h3> | ||
− | <h4>Instructor of department of science, China Pharmaceutical University, secretary of the Communist Youth League | + | <h4><br>Instructor of department of science, |
+ | <br>China Pharmaceutical University, secretary of the Communist Youth League | ||
<br> He was graduated from the China University of Mining and Technology and majored in sports science. After | <br> He was graduated from the China University of Mining and Technology and majored in sports science. After | ||
work in our school, he is long-term focus on guiding students to work and helping students solve the | work in our school, he is long-term focus on guiding students to work and helping students solve the |
Revision as of 14:29, 29 October 2017
Members
CPU_CHINA
![](https://static.igem.org/mediawiki/2017/3/30/T--CPU_CHINA--mb-figure1.jpg)